Found: 10
Select item for more details and to access through your institution.
Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31834-y
- By:
- Publication type:
- Article
The Intersections of COVID-19, HIV, and Race/Ethnicity: Machine Learning Methods to Identify and Model Risk Factors for Severe COVID-19 in a Large U.S. National Dataset.
- Published in:
- AIDS & Behavior, 2024, v. 28, p. 5, doi. 10.1007/s10461-024-04266-6
- By:
- Publication type:
- Article
Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Impact of Nutritional Status on COVID‐19‐Induced Olfactory Dysfunction.
- Published in:
- Laryngoscope, 2024, v. 134, n. 10, p. 4338, doi. 10.1002/lary.31660
- By:
- Publication type:
- Article
Clinical encounter heterogeneity and methods for resolving in networked EHR data: a study from N3C and RECOVER programs.
- Published in:
- Journal of the American Medical Informatics Association, 2023, v. 30, n. 6, p. 1125, doi. 10.1093/jamia/ocad057
- By:
- Publication type:
- Article
Harmonizing units and values of quantitative data elements in a very large nationally pooled electronic health record (EHR) dataset.
- Published in:
- Journal of the American Medical Informatics Association, 2022, v. 29, n. 7, p. 1172, doi. 10.1093/jamia/ocac054
- By:
- Publication type:
- Article
Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Potential drug–drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross‐sectional study of the National Covid Cohort Collaborative (N3C).
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 12, p. 1251, doi. 10.1002/phar.2860
- By:
- Publication type:
- Article
Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2.
- Published in:
- Cardio-Oncology, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40959-023-00187-w
- By:
- Publication type:
- Article
Characterizing the impact of SARS-CoV-2 reinfection on surgical outcomes.
- Published in:
- 2024
- By:
- Publication type:
- Letter